AGFA Gevaert NV
XBRU:AGFB
AGFA Gevaert NV
Agfa-Gevaert NV engages in the development, manufacture, and distribution of analogue and digital imaging systems and information technology (IT) solutions. The company is headquartered in Mortsel, Antwerpen and currently employs 6,993 full-time employees. The Company’s activities are divided into three independent business groups: Agfa Graphics, its dominant segment, which offers integrated pre-press solutions to the printing industry; Agfa HealthCare, which supplies hospitals and other healthcare centers with systems for capturing, processing and managing diagnostic images; and Agfa Specialty Products, which supplies a film-based products and high-tech solutions to business-to-business customers outside the graphic and healthcare markets. The firm is active worldwide through more than 40 wholly-owned sales organizations and runs manufacturing sites in Argentina, Brazil, China, France, Germany, Italy, Japan, South Korea, Taiwan the United Kingdom and the United States.
Agfa-Gevaert NV engages in the development, manufacture, and distribution of analogue and digital imaging systems and information technology (IT) solutions. The company is headquartered in Mortsel, Antwerpen and currently employs 6,993 full-time employees. The Company’s activities are divided into three independent business groups: Agfa Graphics, its dominant segment, which offers integrated pre-press solutions to the printing industry; Agfa HealthCare, which supplies hospitals and other healthcare centers with systems for capturing, processing and managing diagnostic images; and Agfa Specialty Products, which supplies a film-based products and high-tech solutions to business-to-business customers outside the graphic and healthcare markets. The firm is active worldwide through more than 40 wholly-owned sales organizations and runs manufacturing sites in Argentina, Brazil, China, France, Germany, Italy, Japan, South Korea, Taiwan the United Kingdom and the United States.
Radiology Decline: Agfa's medical film business faced a severe drop, with radiology revenue down 20%, especially due to a rapidly shrinking China market.
Cloud Transition: Healthcare IT is shifting quickly to cloud and SaaS, hurting short-term revenue and profit but increasing recurring revenue and order intake.
Cost Actions Accelerated: The group is speeding up and expanding its cost-saving plans, including advancing layoffs and new savings programs, to offset film business declines.
Cash Flow: Positive free cash flow of EUR 21 million in Q3, driven by working capital improvements and AgfaPhoto settlement.
DPC Performance: Digital Printing & Chemicals showed slight top-line and profitability growth, though growth is mostly price-driven, not volume-driven.
Outlook Adjusted: Healthcare IT’s outlook is downgraded to slightly below last year due to the SaaS transition; DPC expects moderate growth; net cash flow for the year still expected to be slightly negative.
